Wright–Giemsa staining of a peripheral blood smear from our patient demonstrated the sheathed microfilariae of W bancrofti (Figure 1). The identification was confirmed by the Centers for Disease Control and Prevention. She was treated with 6 mg/kg diethylcarbamazine orally for 1 day. The patient did not experience any adverse reactions. As her lymphedema was chronic in nature, treatment with diethylcarbamazine would not be expected to reverse existing damage. There are therapeutic methods

which may offer benefit including tailor-made BAY 80-6946 in vitro stockings, limb elevation, light massage of the affected limb, intermittent pneumatic compression jackets, heat therapy, or surgical procedures.9 Infection with W bancrofti is possible in short-term travelers, especially if traveling unprotected (mosquito nets, etc.). One study found that filarial infections accounted for 0.62% of medical conditions reported to the GeoSentinal

Network by travelers.10Onchocerca volvulus was responsible for the greatest number of infections followed by equal numbers of Loa loa and W bancrofti. However, morbidity is linked to long-term exposure and high density of infection which result from continuous exposure. Because the life expectancy of the Wuchereria parasite is 5 years, and our patient was treated in the past, it is likely that she was reinfected during one of her visits selleck inhibitor to Guyana. Both authors state that they have no conflicts of interest to declare. “
“We report the first case of leptospirosis in a patient with a travel history to Mauritius, where the disease has very occasionally been reported in local populations. Following an initial dengue-like presentation, the patient suffered pancreatic involvement and trigeminal neuralgia, which are two unusual delayed features of leptospirosis. An increasing number of imported leptospirosis cases and outbreaks following international travel have been published during the last 10 years, mainly in individuals performing

water sports or in contact with a water surface.1 Leptospirosis is now considered an emerging disease in travelers.2 Although the Diflunisal disease has a worldwide distribution,2 travel-associated cases have mostly been reported from the Asian and American continents.1 The disease has a broad clinical spectrum ranging from asymptomatic infections to fatalities and a number of differential diagnoses may be considered. We report a case with rare clinical manifestations in a patient after a trip to Mauritius Island. A 37-year-old French male spent 10 days in Mauritius in March 2010, as an independent traveler to the island, together with six friends. During this trip, he experienced mosquito bites.